APT Medical

APT Medical Forward P/E

The Forward P/E Ratio of APT Medical (688617.SS) as of Oct 22, 2026 is 40.43. In the previous year, Forward P/E Ratio was 49.29 — a change of -17.97% (lower).

Forward P/E

40.43

YoY

-17.97%

Last updated:

Forward P/E Ratio of APT Medical is 2025 40.43 . Forward P/E Ratio of APT Medical was 2024 49.29 . It decreases by -17.97% lower compared to the previous year.

The APT Medical Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
1,542.27 CNY
Jan 1, 2019
401.78 CNY
Jan 1, 2020
299.50 CNY
Jan 1, 2021
159.57 CNY
Jan 1, 2022
92.67 CNY
Jan 1, 2023
62.14 CNY
Jan 1, 2024
49.29 CNY
Jan 1, 2025
40.43 CNY
The APT Medical Forward P/E history
YEARForward P/EYoY
40.43-17.97%
49.29-20.68%
62.14-32.95%
92.67-41.92%
159.57-46.72%
299.50-25.46%
401.78-73.95%
1,542.27+60.29%
962.15—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

APT Medical Stock analysis

What does APT Medical do? APT Medical Inc generates revenue through the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company offers electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters, and multichannel electrophysiological systems under its electrophysiology product line. Its coronary access segment includes guide wires, micro catheters, balloons, contrast guide wires, and catheters. Peripheral vascular intervention products address peripheral vascular diseases and are sold domestically and internationally. The firm also engages in original equipment manufacturer (OEM) business, producing products for other brands. Domestic and overseas markets are the primary sales channels for all product segments. The company's electrophysiology products target healthcare providers specializing in cardiac procedures, while coronary access devices serve interventional cardiologists and vascular surgeons. Peripheral vascular intervention solutions are marketed to hospitals and clinics treating vascular conditions. OEM partnerships allow APT Medical to supply components to other medical device manufacturers without direct branding. These segments collectively drive revenue through direct sales to healthcare institutions and international distributors. APT Medical Inc's product portfolio includes electrophysiological systems and coronary access tools that cater to specific medical specialties. The firm's peripheral vascular intervention products are designed for treating conditions like peripheral artery disease. OEM business contributes to revenue by manufacturing components for other companies' branded products. Domestic market sales and overseas distribution networks form the core of the company's commercial strategy, with no mention of specific customer names or financial figures beyond the employee count. APT Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about APT Medical stock

Forward P/E Ratio of APT Medical is 40.43 in 2025.

Forward P/E Ratio of APT Medical changed from 49.29 to 40.43, representing a -17.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio APT Medical since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's APT Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — APT Medical

All Key Metrics — APT Medical